Location History:
- Fujian Province, CN (2018 - 2022)
- Xiamen, CN (2015 - 2023)
Company Filing History:
6 out of 153 
3 out of 1,458 
3 out of 15 Years Active: 2015-2023
Title: Innovations of Inventor Tong Cheng
Introduction
Tong Cheng is a notable inventor based in Province, China, recognized for his significant contributions to the field of medical research. He holds a total of six patents, showcasing his innovative approach to treating tumors through viral therapies. His work has the potential to impact cancer treatment significantly.
Latest Patents
Among his latest patents, Cheng has developed a virus for the treatment of tumors, specifically utilizing enterovirus D68 (EV-D68) or its modified forms. This patent includes a nucleic acid molecule comprising a genomic sequence or cDNA sequence of the EV-D68, which can be used in pharmaceutical compositions aimed at treating tumors. Another significant patent involves the use of Echovirus 25 (ECHO25) or its modified forms, which also focuses on the treatment of tumors in subjects. These innovations highlight Cheng's commitment to advancing therapeutic options for cancer patients.
Career Highlights
Cheng has had a distinguished career, working at prominent institutions such as Xiamen University and Rutgers, the State University of New Jersey. His research has been pivotal in exploring the therapeutic applications of viruses in oncology, contributing to the understanding of how these agents can be harnessed for medical benefits.
Collaborations
Cheng has collaborated with esteemed colleagues, including Ningshao Xia and Xiangzhong Ye. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Tong Cheng's work exemplifies the intersection of innovation and medical research, particularly in the field of cancer treatment. His patents reflect a forward-thinking approach that could lead to groundbreaking advancements in oncology.